Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2011 1
2015 1
2016 2
2017 4
2018 2
2019 3
2020 1
2021 3
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Quantitative analysis and carcinogenic/non-carcinogenic risk assessment of aflatoxin M(1) in milk-based baby food and infant formula milk - a case study in Iran.
Kiani A, Sharafi K, Ahmadi Jouybari T, Ahmadi Jouybari H, Biglari H, Ebrahimzadeh G, Fattahi N. Kiani A, et al. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2022 Sep;39(9):1604-1618. doi: 10.1080/19440049.2022.2096931. Epub 2022 Jul 20. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2022. PMID: 35857969
In this study, solid-phase extraction (SPE) combined with the dispersive liquid-liquid microextraction based on novel hydrophobic deep eutectic solvent (DLLME - DES) has been developed as an ultra-pre-concentration technique for the extraction of aflatoxin M(1) (AFM1) in m …
In this study, solid-phase extraction (SPE) combined with the dispersive liquid-liquid microextraction based on novel hydrophobic deep eutec …
Transoral Outlet Reduction to Tackle Weight Regain After Roux-en-Y Gastric Bypass: a Single Center Initial Experience.
Vansteenbrugge L, Strypstein S, Biglari M, Debergh I, Smet B. Vansteenbrugge L, et al. Obes Surg. 2023 Jun;33(6):1646-1651. doi: 10.1007/s11695-023-06580-9. Epub 2023 Apr 17. Obes Surg. 2023. PMID: 37067686
Prospectively collected data on technical feasibility, safety and efficacy are described with a median follow-up of 22 (6-38) months. RESULTS: Mean BMI was 44.5 kg/m(2) at the time of RYGB. Postoperative nadir BMI was 27,7 kg/m(2). ...The mean absolute weight loss w …
Prospectively collected data on technical feasibility, safety and efficacy are described with a median follow-up of 22 (6-38) months. RESULT …
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults.
Toledo-Romani ME, García-Carmenate M, Verdecia-Sánchez L, Pérez-Rodríguez S, Rodriguez-González M, Valenzuela-Silva C, Paredes-Moreno B, Sanchez-Ramirez B, González-Mugica R, Hernández-Garcia T, Orosa-Vázquez I, Díaz-Hernández M, Pérez-Guevara MT, Enriquez-Puertas J, Noa-Romero E, Palenzuela-Diaz A, Baro-Roman G, Mendoza-Hernández I, Muñoz Y, Gómez-Maceo Y, Santos-Vega BL, Fernandez-Castillo S, Climent-Ruiz Y, Rodríguez-Noda L, Santana-Mederos D, García-Vega Y, Chen GW, Doroud D, Biglari A, Boggiano-Ayo T, Valdés-Balbín Y, Rivera DG, García-Rivera D, Vérez-Bencomo V; SOBERANA Research Group. Toledo-Romani ME, et al. Med. 2022 Nov 11;3(11):760-773.e5. doi: 10.1016/j.medj.2022.08.001. Epub 2022 Aug 8. Med. 2022. PMID: 35998623 Free PMC article. Clinical Trial.
A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic.
Beig Parikhani A, Dehghan R, Talebkhan Y, Bayat E, Biglari A, Shokrgozar MA, Ahangari Cohan R, Mirabzadeh E, Ajdary S, Behdani M. Beig Parikhani A, et al. AMB Express. 2024 Feb 9;14(1):19. doi: 10.1186/s13568-023-01648-2. AMB Express. 2024. PMID: 38337114 Free PMC article.
In this study, a novel nanobody-based immunocytokine is developed by the fusion of a mutant (m) IL-2 with a decreased affinity toward CD25 to an anti-vascular endothelial growth factor receptor-2 (VEGFR2) specific nanobody, denoted as VGRmIL2-IC. ...
In this study, a novel nanobody-based immunocytokine is developed by the fusion of a mutant (m) IL-2 with a decreased affinity toward …
KH domain containing 3 like (KHDC3L) frame-shift mutation causes both recurrent pregnancy loss and hydatidiform mole.
Fatemi N, Ray PF, Ramezanali F, Shahani T, Amiri-Yekta A, Kherraf ZE, Cazin C, Almadani N, Varkiani M, Sarmadi S, Sodeifi N, Gourabi H, Biglari A, Totonchi M. Fatemi N, et al. Eur J Obstet Gynecol Reprod Biol. 2021 Apr;259:100-104. doi: 10.1016/j.ejogrb.2021.02.006. Epub 2021 Feb 10. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 33639414
Target gene repression mediated by miR-144 and miR-224 in cumulus cells is related to the success of oocyte in vitro maturation and fertilisation in patients with polycystic ovary syndrome (PCOS).
Shafienia H, Montazeri F, Heydari L, Khalili MA, Mazloomzadeh S, Sheikhha MH, Biglari A. Shafienia H, et al. Reprod Fertil Dev. 2022 Oct;34(17):1089-1098. doi: 10.1071/RD22082. Reprod Fertil Dev. 2022. PMID: 36162418
METHODS: Immature oocytes were retrieved from 20 PCOS patients. After IVM, samples were divided into two groups: matured (M) and immatured (I) oocytes. ICSI was performed and the embryo quality was evaluated. qPCR was used to analyse miR-144, miR-224, COX-2 and PTX-3 expre …
METHODS: Immature oocytes were retrieved from 20 PCOS patients. After IVM, samples were divided into two groups: matured (M) and imma …
Collision of the glass shards with the eye: A computational fluid-structure interaction model.
Karimi A, Razaghi R, Biglari H, Sera T, Kudo S. Karimi A, et al. J Chem Neuroanat. 2018 Jul;90:80-86. doi: 10.1016/j.jchemneu.2017.12.008. Epub 2017 Dec 27. J Chem Neuroanat. 2018. PMID: 29288709
To do this, a rigid steel-based object hit a Smoothed-Particle Hydrodynamics (SPH) glass wall at the velocities of 100, 150, and 200 m/s and, subsequently, the resultant glass shards moved toward the eye. ...
To do this, a rigid steel-based object hit a Smoothed-Particle Hydrodynamics (SPH) glass wall at the velocities of 100, 150, and 200 m
21 results